Evidence map›Paper›PMID 20728077›Full record

ArticleCellular immunology2010

Differential requirement of lipid rafts for FcγRIIA mediated effector activities.

Joshua A Vieth, Moo-Kyung Kim, Xiao Qing Pan, Alan D Schreiber, Randall G Worth

Open access · greenAbstract read
In one paragraph

Article in Cellular immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Lipid rafts as viral entry routes and immune platforms: A double-edged sword in SARS-CoV-2 infection?Biochimica et biophysica acta. Molecular and cell biology of lipids · 2022
    Review
  4. Review
  5. Article
  6. Article
  7. SREBP-1a-stimulated lipid synthesis is required for macrophage phagocytosis downstream of TLR4-directed mTORC1.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  8. Article
  9. FcγRIIa requires lipid rafts, but not co-localization into rafts, for effector function.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2013
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Joshua A ViethDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine, Toledo, OH 43614, USA.
Moo-Kyung Kim
Xiao Qing Pan
Alan D Schreiber
Randall G Worth
University of Pennsylvania · USUniversity of Toledo Medical Center · US

Funding

HUMAN BLOOD MONOCYTE RECEPTOR EXPRESSION AND MODULATIONR01AI022193 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SCHREIBER, ALAN D · 1985 to 2010
$4.9M
THE HUMAN PLATELET IN IMMUNOHEMATOLOGIC DISEASER01HL028207 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI SCHREIBER, ALAN D · 1985 to 2006
$2.8M
NHLBI NIH HHS R01 HL028207NIAID NIH HHS R01 AI022193
6 · The paper itself

Abstract

Immunoglobulin G (IgG) dependent activities are important in host defense and autoimmune diseases. Various cell types including macrophages and neutrophils contribute to pathogen destruction and tissue damage through binding of IgG to Fcγ receptors (FcγR). One member of this family, FcγRIIA, is a transmembrane glycoprotein known to mediate binding and internalization of IgG-containing targets. FcγRIIA has been observed to translocate into lipids rafts upon binding IgG-containing targets. We hypothesize that lipid rafts participate to different extents in binding and internalizing targets of different sizes. We demonstrate that disruption of lipid rafts with 8mM methyl-β-cyclodextrin (MβCD) nearly abolishes binding (91% reduction) and phagocytosis (60% reduction) of large IgG-coated targets. Conversely, binding and internalization of small IgG-complexes is less dependent on lipid rafts (49% and 17% inhibition at 8mM MβCD, respectively). These observations suggest that differences between phagocytosis and endocytosis may arise as early as the initial stages of ligand recognition.

Indexed as

Animalsbeta-CyclodextrinsCHO CellsCricetinaeCricetulusEndocytosisHumansImmunoglobulin GLigandsMembrane MicrodomainsPhagocytosisProtein BindingReceptors, IgGbeta-CyclodextrinsFc gamma receptor IIAImmunoglobulin GLigandsmethyl-beta-cyclodextrinReceptors, IgG

Identifiers

PMID20728077
PMCPMC2975250
OpenAlexW2082986236

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.